Options
Response to Hasan et al's “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma
Other Title
A retrospective cohort study”
Journal
Journal of the American Academy of Dermatology
Date Issued
2024-11-01
Author(s)
Type
journal article